Brief warning about interpreting these studies: The primary treatment in these studies is the therapy, and the drug is only provided in limited sessions to augm

Brief warning about interpreting these studies: The primary treatment in these studies is the therapy, and the drug is only provided in limited sessions to augment the therapy. You cannot replicate these results by taking MDMA ad-hoc without the therapy. In this case, the study used 10 or more therapy sessions without MDMA. As a caveat, more members of the MDMA arm completed all therapy sessions, and the MDMA arm also had more patients opting for additional therapy sessions, which seems like a strange confounded to allow: > Additionally, 14 participants (10 of whom were in the MDMA arm) requested further integrative visits, as permitted by the protocol. The placebo group also scored significantly worse on 2 out of 3 measures of depression prior to starting the study, which is another strange discrepancy that can’t be dismissed. It’s good to see more studies in this area, but we need to be careful to not assume that drugs alone will fix these problems. Keep in mind that the therapy was significantly effective in the non-MDMA group as well. At least some of the difference between groups can be attributed to the starting differences between groups and the additional therapy received by the MDMA group.